Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)-Reference-Cited by-同舟云学术

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Published:2019-12-12 Issue:2 Volume:11 Page:353-361
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Ruiz‐Patiño Alejandro¹²,Arrieta Oscar³,Cardona Andrés F.¹²⁴^ORCID,Martín Claudio⁵,Raez Luis E.⁶,Zatarain‐Barrón Zyanya L.³,Barrón Feliciano³,Ricaurte Luisa¹,Bravo‐Garzón María A.⁷,Mas Luis⁸,Corrales Luis⁹,Rojas Leonardo⁴¹⁰,Lupinacci Lorena¹¹,Perazzo Florencia¹²,Bas Carlos¹³,Carranza Omar¹⁴,Puparelli Carmen⁵,Rizzo Manglio¹⁵,Ruiz Rossana⁷,Rolfo Christian¹⁶,Archila Pilar¹,Rodríguez July¹,Sotelo Carolina¹,Vargas Carlos¹²⁴,Carranza Hernán¹²⁴,Otero Jorge¹²⁴,Pino Luis E.¹⁷,Ortíz Carlos⁴,Laguado Paola⁴,Rosell Rafael¹⁸¹⁹²⁰,

Affiliation:

1. Foundation for Clinical and Applied Cancer Research (FICMAC) Bogotá Colombia

2. Molecular Oncology and Biology Systems Research Group (FOX‐G), Universidad el Bosque Bogotá Colombia

3. Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan) México City Mexico

4. Clinical and Translational Oncology GroupInstitute of Oncology, Clínica del Country Bogotá Colombia

5. Medical Oncology Department, Thoracic Oncology SectionInstituto Fleming Buenos Aires Argentina

6. Thoracic Oncology ProgramMemorial Cancer Institute/Florida International University Miami Florida USA

7. Hematology and Oncology DepartmentHospital Militar Central Bogotá Colombia

8. Oncology DepartmentInstituto Nacional de Enfermedades Neoplásicas – IneN Lima Peru

9. Medical Oncology DepartmentHospital San Juan de Dios San José Costa Rica

10. Oncology DepartmentClínica Colsanitas Bogotá Colombia

11. Thoracic Oncology UnitHospital Italiano de Buenos Aires Buenos Aires Argentina

12. Section of OncologyCEMIC Buenos Aires Buenos Aires Argentina

13. Oncology DepartmentHospital Alemán Buenos Aires Argentina

14. Oncology DepartmentHospital Privado de la Comunidad de Mar del Plata Mar del Plata Argentina

15. Oncology DepartmentHospital Austral de Buenos Aires Buenos Aires Argentina

16. Thoracic Oncology Unit, Marlene and Stewart Comprehensive Cancer CenterUniversity of Maryland Baltimore MD USA

17. Oncology DepartmentInstitute of Oncology – ICAL, Fundación Santa Fe de Bogotá Bogotá Colombia

18. Coyote Research Group, Pangaea Oncology, Laboratory of Molecular BiologyQuiron‐Dexeus University Institute Barcelona Spain

19. Institut d'Investigació en Ciències Germans Trias i Pujol Badalona Spain

20. Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona Spain

Funder

Foundation for Clinical and Applied Cancer Research

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13272

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. Incidence and mortality of lung cancer: global trends and association with socioeconomic status

4. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

5. First‐line treatment in EGFR mutant non‐small cell lung cancer: Is there a best option?;Bulbul A;Front Oncol,2018

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody nanoparticle conjugate–based targeted immunotherapy for non–small cell lung cancer;Science Advances;2024-06-14

2. Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer;2024-06-11

3. Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer;2024-06-11

4. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study;Drugs & Aging;2024-05

5. Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer;2024-04-20